Hologic announced that it has entered into a definitive agreement to be acquired by private equity firms Blackstone and TPG in a deal valued at up to $18.3 billion. This transaction will take Hologic private.
Under the terms of the agreement, Blackstone and TPG will acquire all outstanding shares of Hologic for $76 apiece in cash. An additional contingent value right (CVR) could entitle shareholders to receive up to $3.00 per share in two payments, contingent on achieving certain global revenue goals for Hologic's Breast Health business in fiscal years 2026 and 2027.
This acquisition represents a significant premium for Hologic shareholders and marks a transformative event for the company. The deal is expected to close in the first half of 2026, pending approval from Hologic shareholders and customary closing conditions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.